Biotechnology Press Releases & Articles 21 - 25 of 33
Trial Shows Adult Stems Could Be Effective For Diabetes
18th December 2009 -
Views: 1483
Australia's regenerative medicine company, Mesoblast Limited (ASX: MSB), today announced significant preclinical trial results showing that the proprietary adult stem cell platform could be an effective treatment for diabetes.
Novavax Launches Pivotal Clinical Study Of Novel 2009 H1n1 Vlp Flu Vaccine In Mexico
20th October 2009 -
Views: 1612
Novavax, Inc. (Nasdaq: NVAX) announced today that it has initiated a two-stage clinical study of its virus-like-particle (VLP) H1N1 influenza vaccine in Mexico in collaboration with Avimex Laboratories (Avimex) and GE Healthcare.
Don't Delay, Vaccinate Today 5
14th October 2009 -
Views: 1598
The call to action comes on the eve of the 13th Asian Pacific Congress of Pediatrics to be held in China at the Shanghai International Convention Center, which aims to address health issues affecting children in Asia.
Neostem Featured In Business Week; 'promising' Adult Stem Cell Market Discussed In Fortune-cnnmoney.
23rd June 2009 -
Views: 1189
NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long- term storage of adult stem cells for future medical need, was featured in Gene Marcial's prominent Business Week column, "Inside Wall Street," on June 18, 2009.
Australia: Face Mask That Kills Swine Flu Readied For Australian Pandemic Fight
11th June 2009 -
Views: 1714
With a four-fold increase in swine flu cases within the last week, Filligent, the Australian-led biotech company, is mobilizing stocks of its anti-infective BioMask to help combat the spread of Influenza A (H1N1) across Australia.
NEWS 
